Patrick Taylor Horn

Chief Medical Officer, Tetraphase Pharmaceuticals (United States).

Companies

Fulcrum Therapeutics (United States)Chief Medical Officer Mar 20, 2024 to Mar 20, 2024¹
ALBIREO PHARMA, INC.Chief Medical Officer Aug 8, 2018 to Oct 25, 2021²
Tetraphase Pharmaceuticals (United States)Chief Medical Officer Mar 19, 2013 to Jun 14, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ALBIREO PHARMA, INC.12,355 shares⁴Oct 22, 2021
Fulcrum Therapeutics (United States) FULC0 shares⁵Mar 20, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 22, 2021Sold 95 shares at $28.83 of ALBIREO PHARMA, INC.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFulcrum Therapeutics (United States), Chief Medical Officer
2
SEC EDGARALBIREO PHARMA, INC., Chief Medical Officer
3
SEC EDGARTetraphase Pharmaceuticals (United States), Chief Medical Officer
4
SEC EDGARALBIREO PHARMA, INC. shares after the filing of Oct 22, 2021
5
SEC EDGARFulcrum Therapeutics (United States) shares after the filing of Mar 20, 2024